Evaluacion de disnea
-
Upload
ninelys-cod -
Category
Documents
-
view
213 -
download
0
Transcript of Evaluacion de disnea
-
8/3/2019 Evaluacion de disnea
1/5
Am JRespir Crit Care Med Vol 158. pp 11851189, 1998Internet address: www.atsjournals.org
Analysis of Clinical Methods Used to Evaluate Dyspneain Patients with Chronic Obstructive Pulmonary Disease
TAKASHI HAJIRO, KOICHI NISHIMURA, MITSUHIRO TSUKINO, AKIHIKO IKEDA,HIROSHI KOYAMA, and TAKATERU IZUMI
Department of Respiratory M edicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
When dyspnea must be assessed clinically, there are three methods of assessment: the measurement
of dyspnea with activities of daily living using clinical dyspnea ratings such as the modified M edical
Research Council (M RC), the Baseline Dyspnea Index (BDI) , and the Oxygen Cost Diagram (OCD);
the measurement of dyspnea during exercise using the Borg scale; to assess the influence of dys-
pnea on health-related quality of life (HRQoL) using disease-specific questionnaires such as the St.
Georges Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire
(CRQ). The purpose of the present cross-sectional study was to clarify relationships between dyspnea
ratings and HRQoL questionnaires by applying factor analysis. One hundred sixty-one patients with
mild to severe COPD completed pulmonary function tests, progressive cycle ergometer testing for
exercise capacity, assessment of dyspnea, HRQoL, anxiety, and depression. Factor analysis demon-
strated that the MRC, BDI, OCD, and Activity of the SGRQ, and Dyspnea of the CRQ, were grouped
into the same factor, and the frequency distribution histograms of these five measures showed virtu-ally the same distribution. The Borg scale at the end of maximum exercise was found to be a different
factor. The MRC, BDI, OCD, and Activity in the SGRQ, and Dyspnea in the CRQ demonstrated the
same pattern of correlation with physiologic data, and they had significant relationships with FEV1(correlation coefficients [Rs] 0.31 to 0.48) and maximal oxygen uptake (Rs
0.46 to 0.60) . Disease-
specific HRQoL questionnaires, the SGRQ and the CRQ, which contain a specific dimension for evalu-
ating dyspnea, may be substituted for clinical dyspnea ratings in a cross-sectional assessment. Dys-
pnea rating at the end of exercise may provide further information regarding dyspnea. Hajiro T,
Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to
evaluate dyspnea in patients with chronic obstructive pulmonary disease.
AM JRESPIR CRIT CARE MED 199 8;158 :1185 1189.
The evaluation of dyspnea in patients with COPD should beincluded among standard measures of physiologic lung func-
tion since dyspnea ratings and lung function are separate fac-
tors that independently characterize the condition of pat ientswith COPD (1). Dyspnea with activities of daily living (ADL)
has been measured using clinical dyspnea ra tings such as thoseof the modified Medical Research Council (MRC) (2), the
Baseline D yspnea Index (BD I) (3), and the O xygen Cost Dia-gram (O CD ) (4), all of which have been widely used. Dyspnea
during exercise testing or with physical activity has been mea-sured with the Borg scale (5), or the V isual A nalog Scale (6).
Arbitrary choices on the dyspnea scale have been made inclinical trials when clinical evaluation of dyspnea was utilized
as one of the out come measures.
On the other hand, an important aim of medical interven-
tions may be to improve no t only the quan tity of life but alsothe quality of life of each patient. Because the term health-
related quality of life (HRQoL) is widely used to describehow the quality of life of patients is affected by health and dis-
ease status, a well-designed HR QoL questionnaire should en-compass comprehensive dimensions that quantify the overall
effect of disease on the patien ts daily life and sense of well be-ing (7, 8). In patients with COPD, it is essential for a measure
of HR QoL to include an assessment of influences attributableto dyspnea. Disease-specific questionnaires for COPD have a
specific dimension in which the impacts of dyspnea on patient
health status are supposed to be evaluated (8, 9).Presently there are three possible ways to assess dyspnea
clinically: the measurement of dyspnea during ADLs usingclinical dyspnea ratings, the measurement of dyspnea during
exercise testing in laboratories using dyspnea ratings, and theassessment of the influence of dyspnea on H RQ oL using a dis-
ease-specific questionnaire. We speculate that a disease-spe-cific HRQoL questionnaire can evaluate dyspnea as well as
clinical dyspnea ratings can. The purpose of the present cross-sectional study was to clarify interrelationships between clini-
(
Received in original form February 19, 1998 and in revised form June 11, 1998
)
Correspondence and requests for reprints should be addressed to Takashi Hajiro,M.D., Department of Respiratory Medicine, Graduate School of Medicine, Kyoto
University, Sakyo, Kyoto, 606-8507, Japan. E-mail: [email protected] o-u.ac.jp
-
8/3/2019 Evaluacion de disnea
2/5
1186
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 158 1998
cal dyspnea ratings, dyspnea ratings at maximal exercise, and
HR QoL questionnaires by applying factor analysis (10), andto clarify the suitability of evaluating patient dyspneic status
using the various methods.
METHODS
Patients with stable CO PD defined by the A merican Thoracic Society
(11) were recruited at the out patient clinic. All patients had more tha n
6 mo of outpatient management before entry to avoid substantial
changes in subjective parameters brought about by new medical inter-
ventions (12). Entry criteria for the study were: (
1
) a FEV
1
/FVC ratio
of less than 0.7 and FEV
1
of less than 80% of the predicted value for
all measurements made during the previous 6 mo; (
2
) smoking history
of more than 20 pack-yr; (
3
) no history suggestive of asthma; (
4
) no
exacerbation of airflow limitation in the preceding 6 wk; and (
5
) no
changes in treatment regimen during the preceding 4 wk. All eligible
patients underwent the following examinations on the same day.
Inhalation of bronchodilators was withheld for at least 12 h before
pulmonary function tests were performed. FEV
1
and FVC were as-
sessed before and 60 min after the inhalation of 400
g of salbutamol
and 80
g of ipratropium bromide using a metered-dose inhaler with a
spacer device (InspirEase; Schering-Plough K.K, Osaka, Japan). All
spirometric flowvolume curves were recorded according to the
method described in the American Thoracic Society 1994 update (13).
The predicted values for FEV
1
and vital capacity (VC) were calcu-
lated according to the proposal of the Japan Society of Chest Diseases
(14). The residual volume (RV) was measured by the closed-circuit
helium method and the diffusion capacity for carbon monoxide
(D
LCO
) was measured using the single-breath technique (CH ESTAC-
65V; Chest, Tokyo, Japan). The progressive exercise test to a symp-
tom-limited maximum was performed using an electrically braked cy-
cle ergometer (Corival WLP-400; Lode, Groningen, The Netherlands)
at 60 min after the inhalation of the bronchodilators as described by
Ikeda and colleagues (15). The workload was increased automatically,
and patients maintained a pedaling frequency above 40 cycles/min
throughout the test. Exercise data were re corded using an automated
exercise testing system (Desktop Diagnostics/CPX; Medical Graphic
Corp., St. Paul, MN). At the end of each exercise test, maximum oxy-
gen uptake (
O2
max) was calculated and breathlessness was scored
with the Bo rg scale (0 to 10) (5).
To assess dyspnea, the Japanese version of the modified MRC (2),the BD I (3, 16), and the OCD (4) were used. The MR C is a five-point
scale based on degrees of various physical activities that precipitate
dyspnea. The BD I recognizes five grades for each o f the following cat-
egories: functional impairment, magnitude of task, and magnitude of
effort. The OCD is a visual analog scale that corresponds to oxygen
requirements at different activity levels, which was represented as a
value ranging from zero to 100, with a score of 100 indicating no im-
pairment. The HRQoL was assessed by the Japanese version of the
St. Georges Respiratory Questionnaire (SGRQ ) (8) and the Chronic
Respiratory Questionnaire (CRQ) (9), which have been precisely val-
idated (17). The SGRQ has three dimensions: Symptoms, concerned
with respiratory symptoms; Activity, concerned with activities that
evoke or are limited by dyspnea; and Impacts, a measure of the over-
all disturbance. The CR Q has four components: Dyspnea, E motional
Function, Mastery, and Fatigue. In the Dyspnea dimension, each pa-
tient defined the five items in terms of ADL limited by disease. TheJapanese version of the Hospital Anxiety and Depression Scale (HAD )
(18) was used for evaluating patients anxiety and depression status.
All results are presented as mean
SD. The relationship between
two sets of data was analyzed by Spearmans rank correlation test. A
p value of less than 0.01 was considered to b e stat istically significant.
Factor analyses was used to determine the dimensions underlying
the pa ttern of interrelationships and t o reduce a large set of variables
to smaller sets of factors (10). Factor analysis may be regarded as a
data reduction technique. In factor analysis, a matrix of correlations
between variables is created, and the n data are tran sformed into lin-
ear combinations of variables that share common variance between
measures. The correlations between the original variables and the lin-
ear combinations or factors are called factor loadings. By examining
which variables loaded highly on each factor, the factors were inter-
V
preted and named. We incorporated the following variables in this
factor analysis: MRC, BDI, OCD, the Borg scale, three dimensions of
the SGRQ, the four components of the CRQ, and Anxiety and De-
pression of the HA D.
RESULTS
A total of 161 consecutive patients (160 men) with mild to se-vere COPD, and having a wide range of FEV
1
predicted val-
ues, were studied (Table 1). One hundred fifty-seven pa tients
were treate d with inhalation of both 400
g of salbutamol and80
g of ipratropium bromide more than four times a day.Seven patients were managed with long-term domiciliary oxy-
gen therapy. Four pa tients received no medication.
A summary of the varimax rotation of the factor a nalysis isprovided in Table 2. Three factors accounted for 70.0% of the
total variance of the data. The MRC, the BDI, the OCD, Ac-tivity in the SGR Q, and D yspnea in the CR Q loaded pred om-
inantly on Factor 1, which appeared to be the
dyspnea
fac-tor. Factor 2 included scores of anxiety and depression on t he
HAD, and appeared to be related to psychological status.Symptoms in the SGRQ and Fatigue, Emotion, and Mastery
in the CRQ loaded predominantly on Factor 3. Using theBorg scale, however, the dyspnea rating after maximal exercise
was found not to be grouped with any of the factors above. On
the basis of these results, we focused on Factor 1, the
dys-pnea
factor, in which the MRC, the BDI, the OCD, Activityin the SGR Q, and Dyspnea in the CRQ were grouped.
The frequency distribution histograms of the MRC, the
BDI, the OCD, Activity in the SGRQ, and Dyspnea in theCRQ are represented in Figure 1. These histograms demon-
strated virtually normal distributions.
TABLE 1
PATIENT CHARACTERISTICS IN 161 PATIENTS WITH COPD
Mean
SD Range
Sex, M/F 160/1
Age, yr 69
7 4889FEV
1
, L 1.06
0.49 0.172.65
FEV
1
, % pred 40.0
17.5 6079.8
Postbronchodilator FEV
1
, % pred 47.9
17.4 15.787.6
RV/TLC, % 46.9
10.3 26.171.2
D
LCO
, % pred 65.1
19.5 30.5131.2
Clinical dyspnea ratings
MRC score (04) 1.0 0.8 04
BDI score (012) 7.9 2.6 212
OCD (0100), mm 62 19 8100
Exercise test
O2
max, mL/min 829
270 2021,625
Borg score at the end of exercise 6.0
1.5 310
HAD
Anxiety (021) 3.9
3.3 017
Depression (021) 5.0
3.7 016
HRQoL questionnaires
SGRQ
Symptoms (0100) 52.5
19.9 7.8100
Activity (0100) 47.5
21.9 0100
Impact (0100) 25.7
16.9 075.6
CRQ
Dyspnea (535) 26.2
5.7 1135
Fatigue (428) 19.8
5.0 428
Emotional function (749) 39.5
7.0 1949
Mastery (428) 22.0
4.3 1128
Definition of abbreviations
: RV
residual volume; MRC
Medical Research Council;
BDI
Baseline Dyspnea Index; OCD
Oxygen Cost Diagram; O
2
max
maximum
oxygen up take; HAD
Hospital Anxiety and Depression Scale; HRQoL
health-related
quality of life; SGRQ
St. Georges Respiratory Questionnaire; CRQ Chronic Respira-
tory Disease Questionnaire.
* Numbers in parentheses represent the theoretical score range.
V
V
-
8/3/2019 Evaluacion de disnea
3/5
Hajiro, Nishimura, Tsukino, et al.
: Dyspnea and Health-related Quality of Life 1187
Correlations between dyspnea ratings, HR QoL, and physi-ological data are shown in Table 3. Selected physiological vari-
ables were FEV
1
, RV/TLC, and O2
max representing airflowlimitation, hyperinflation, and exercise capacity, respectively.
The MRC, the BDI, the OCD, Activity in the SGRQ, andDyspnea in the CRQ displayed an almost identical pattern in
correlations with physiologic data. All of these had significantrelationships with FE V
1
(correlation coefficient [Rs]
0.31 to
V
0.48), and the O CD showed the strongest correlation. Measure-
ment of O2
max were correlated significantly with the
dys-
pnea
factor (Rs
0.46 to 0.60). There were no significant
correlations between RV/TLC a nd the BD I or Dyspnea in theCRQ. In contrast, the Borg scale at the end of exercise had no
significant relationship with FEV
1
, RV/TLC, or O2
max.
DISCUSSION
This cross-sectional study showed that factor a nalysis grouped
clinical dyspnea ratings (the MRC, the BDI, and the OCD)and two dimensions of the disease-specific HR QoL question-
naires under the same factor, and these five measures per-formed almost the same in assessing dyspnea in patients with
COPD. The Borg scale was found to evaluate a different as-pect of dyspnea using the methods mentioned above. HR QoL
questionnaires that contain a specific dimension for evaluatingdyspnea may be substituted for clinical dyspnea ratings in a
cross-sectional assessment.The factors grouped by factor analysis facilitated the selec-
tion of individual variables that may most closely representthe conceptual mean ing of the composite variable (10). In the
present study, it is reasonable to suppose that the MRC, theBDI, the OCD, Activity of the SGRQ, and Dyspnea of the
CRQ, which constituted Factor 1, have the same conceptualmeaning in common. These five methods may evaluate thesame aspect of dyspnea even though different approaches are
taken in each method to quantify dyspnea. The BDI and D ys-pnea of the CRQ present questions regarding the level of dys-
pnea that is provoked by patients ADL, and unidimensionalmeasures (the MRC, the OCD) de tect the threshold of activities
that bring physical limitations caused by breathlessness (16). In
V
V
TABLE 2
ROTATED FACTOR LOADINGS FROM FACTOR ANALYSISIN 161 PATIENTS WITH COPD
Factor 1 Factor 2 Factor 3
Factor 1: dyspnea
MRC 1.00
0.10 0.23
BDI
0.85 0.05 0.07
OCD
0.92 0.11
0.24
Activity, SGRQ 0.81
0.06 0.17
Dyspnea, CRQ
0.55 0.12 0.34Factor 2: psychological status
Anxiety, HAD 0.00 0.91 0.00
Depression, HAD 0.15 0.86 0.00
Factor 3: other HRQoL
Symptoms, SGRQ 0.28
0.23
0.66
Fatigue, CRQ
0.15
0.17 0.66
Emotional function, CRQ 0.00
0.35 0.70
Mastery, CRQ 0.06
0.21 0.73
Other factors
Impact, SGRQ 0.47
0.06
0.44
Borg score at the end of the exercise 0.00 0.00 0.00
For definition of abbreviations, see
Table 1.
Figure 1. Frequency distribution histograms represent the scores of dyspnea assessments. In the MedicalResearch Council (MRC) and Activity of the St. Georges Respiratory Questionnaire (SGRQ), higher scoresindicate more severe dyspnea. In the Baseline Dyspnea Index (BDI), the Oxygen Cost Diagram (OCD),and the Chronic Respiratory Disease Questionnare (CRQ), higher scores indicate less impairment. Num-bers in parentheses represent the theoretical score range.
-
8/3/2019 Evaluacion de disnea
4/5
1188
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 158 1998
Activity of the SGR Q (8), patients were asked to indicate withyes-no answers whether or not activities such as sitting, walk-
ing, or playing sports usually make them feel breath less.Add itionally, score distributions showed that the MR C, the
BDI, the OCD, Activity of the SGRQ, and Dyspnea of theCRQ have almost the same level of discriminatory power in
accordance with a wide range of disease severity despite dif-
ferences in the number of items, grading scales, and scoring ofeach method. Dyspnea of the CRQ (9) was developed as an
evaluative and not as a discriminative measure because pa-tients quantify their dyspnea during five self-selected activities
and the score in this dimension is individualized. However,our study showed that D yspnea in the CRQ was also discrimi-
native. With regard to the relationships of these methods withphysiologic parameters, expected information was obtained
such as mild correlations with airflow limitation and moder-ate-to-strong correlations with exercise capacity (19, 20). These
correlations further demonstrated minor differences, and this
suggests that these five measures may be similar in the valid-ity. These observations can lead us to suppose that arbitrary
choices of measures within the
dyspnea
factor, that is, the
MRC, the BDI, the OCD, Activity of the SGRQ, and Dys-
pnea of the CRQ may not make any significant difference when
clinical cross-sectional assessment for dyspnea is mandatory.The statistical method of factor analysis has been used pr e-viously to clarify the relationships between various parame-
ters in patients with CO PD, and our results partly support t hefindings of previous studies. Mahler and Harver (1) demon-
strated that clinical dyspnea ratings consisted of an indepen-dent factor, using principal-componen t factor ana lysis, although
they did not evaluate patients with an HRQoL questionnaire.Wegner and colleagues (20) also used factor analysis in patients
with moderate-to-severe COPD and demonstrated that dys-pnea ratings (the MR C, the OCD , and the BDI) and quality of
life evaluated with the CR Q re presented one independent en-
tity. It is not clear from their analysis how Dyspnea in theCRQ and the other t hree dimensions correlated with dyspnea
ratings and other parameters because they adopted the totalscore of t he CR Q in their analysis instead of the scores of the
four separate dimensions. In fact, Fatigue, Emotional Func-tion, and Mastery of the CRQ were grouped as a different fac-
tor from the
dyspnea
factor in the pre sent study. Incorporat-ing each dimension of the HRQoL questionnaires separately
into factor analysis may be mor e appr opriate in pr oviding in-sight into interrelationships between clinical dyspnea ratings
and HRQ oL.It is of interest to note that the Borg scale at the end of
symptom-limited exercise was found to be a completely sepa-rate entity in this factor analysis. This suggests that the Borg
scale may evaluate a different aspect of dyspnea from thatevaluated by other dyspnea r atings. The re asons for this may
be as follows: the intensity of an exercise task as measured by
the ergometer does not reflect patients A DL since they tendto avoid strenuous exercise in their daily life once they recog-
nize it causes dyspnea; lower-extremity symptoms can limitexercise performance and affect the sensation of dyspnea as
Mahler and Harver (21) demonstrated; the Borg scale is de-scribed as a direct measure since the patients are asked to
score sensations while they are actually experiencing dyspnea,
whereas patients reflecting on their daily life answer clinicaldyspnea ra tings indirectly (22).
The present study has some limitations. First, the cross-sec-tional analysis does not address the responsiveness of each
measure over time. Second, because our study included pre-dominantly men, generalization of t he r esults to women with
COPD may be uncertain.In conclusion, clinical dyspnea ratings (the MRC, the BDI,
the OCD) and Activity of the SGRQ and Dyspnea of theCRQ were grouped under the same factor, and these five
methods performed virtually identically in evaluating dyspneain patients with COPD . On the other han d, dyspnea at the end
of maximal exercise may provide a different type of informa-
tion regarding dyspnea. Disease-specific HRQoL question-naires may be substituted for clinical dyspnea ratings in the
cross-sectional assessment. Taken in the light of the growing
prevalence of HRQoL and its questionnaires as one measureof outcome, these observations may afford another perspec-tive on the measurement of dyspnea in clinical trials.
References
1. Mahler, D. A., and A . Harver. 1992. A factor analysis of dyspnea ratings,
respiratory muscle strength, and lung function in patients with chronic
obstructive pulmonary disease.A m. Rev. R espir. Dis.
145:467470.
2. Brooks, S. M. 1982. Surveillance for respiratory hazards. ATS News
8:
1216.
3. Mahler, D. A., D. H. Weinberg, C. K. Wells, and A. R. Feinstein. 1984.
The measurement of dyspnea: contents, interobserver agreement, and
physiologic correlates of two new clinical indexes. Chest
85:751758.
4. McGravin, C. R., M. Artvinli, and H. Naoe. 1978. Dyspnoea, disability,
and distance walked: comparison of exercise performance in respira-
tory disease.B.M.J.
2:241243.5. Borg, G. A. V. 1982. A category scale with ratio prope rties for inter-
modal and interindividual comparisons.In
H. G. Geissler and P. Pet-
zold, editors. Psychophysical Judgment a nd the Process of Perception.
Veb D eutscher Ve rlag der W issen Schaften, Ber lin. 2534.
6. Stervus, S. S., and E. H . Galunter. 1957. Ratio scales and category scales
for a dozen perceptual continua.J. Exp. Psychol.
54:377411.
7. Ware, J. E., and C. D. Sherbourne. 1992. The MOS 36-Item Short-Form
Health Survey (SF-36).Med. Care
30:474483.
8. Jones, P. W., F. H. Quirk, C. M. Baveystock, and P. Littlejohns. 1992. A
self-complete measure of health status for chronic airflow limitation:
The St. Georges Respiratory Questionnaire.Am . Rev. R espir. Dis.
145:
13211327.
9. Guyatt, G. H., L. B. Berman, M. Townsend, S. O. Pugsley, and L. W.
Chambers. 1987. A measure of quality of life for clinical trials in
chronic lung disease. Thorax
42:773778.
10. Ries, A. L., R. M. Kaplan, and E . Blumberg. 1991. Use of factor analysis
to consolidate multiple outcome measures in chronic obstructive pul-
monary disease.J. Clin. Epidermiol.
6:497503.
11. Amer ican Thoracic Society. 1987. Standard s for the diagnosis and care
of patients with chronic obstructive pulmonary disease (COPD) and
asthma.A m. Rev. R espir. Dis.
136:225244.
12. Harlan, L. C., B. F. Polk, S. Cooper, T. P. Blaszkowski, S. J. Ignatius, M.
Stromer, and H. Muller. 1986. Effects of labeling and tr eatmen t of hy-
pertension on perceived health.A m. J. Prev. Med.
2:256265.
13. Amer ican Thoracic Society. 1994. Standardization of spirometry. 1994
update.A m. Rev. R espir. Dis.
152:11071136.
14. Japan Society of Chest Diseases. 1993. The predicted values of pulmo-
nary function testing in Japanese. Jpn. J. Thoracic Dis.
31:Appendix
[in Japanese].
15. Ikeda, A., K. Nishimura, H. Koyama, M. Tsukino, M. Mishima, and T.
Izumi. 1996. Dose response study of oxitropium bromide aerosol on
TABLE 3
SPEARMANS RANK CORRELATIONS BETWEEN DYSPNEARATINGS, HRQoL, AND PHYSIOLOGICAL VARIABLES
IN 161 PATIENTS WITH COPD
MRC BDI OCD Activity, SGRQ Dyspnea, CRQ
FEV
1
0.39 0.31 0.48
0.36 0.35
RV/TLC 0.23
0.14*
0.31 0.25
0.19*
O2
max
0.60 0.46 0.56
0.55 0.46
For definition of abbreviations, see
Table 1.
All values listed represent statistically significant relationships (p
0.01) except thetwo values indicated w ith asterisks.
V
-
8/3/2019 Evaluacion de disnea
5/5